Loading...
OTCMBOEUF
Market cap2.31bUSD
Dec 20, Last price  
34.88USD
1Q
12.46%
IPO
541.16%
Name

Bonesupport Holding AB

Chart & Performance

D1W1MN
OTCM:BOEUF chart
P/E
103.93
P/S
43.08
EPS
3.72
Div Yield, %
0.00%
Shrs. gr., 5y
5.17%
Rev. gr., 5y
43.65%
Revenues
591m
+79.76%
40,961,00061,755,000104,599,000129,301,00096,623,000155,462,000180,860,000212,885,000328,818,000591,077,000
Net income
245m
P
-51,065,000-59,555,000-110,190,000-128,869,000-176,405,000-161,060,000-101,412,000-85,531,000-68,167,000245,021,000
CFO
-18m
L-61.14%
-45,923,000-65,292,000-81,933,000-107,534,000-171,625,000-163,828,000-100,275,000-83,421,000-46,985,000-18,257,000
Earnings
Feb 13, 2025

Profile

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.
URL
https://www.bonesupport.com
IPO date
Jun 21, 2017
Employees
104
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
591,077
79.76%
328,818
54.46%
212,885
17.71%
Cost of revenue
568,884
395,952
298,158
Unusual Expense (Income)
NOPBT
22,193
(67,134)
(85,273)
NOPBT Margin
3.75%
Operating Taxes
(229,273)
3,473
3,694
Tax Rate
NOPAT
251,466
(70,607)
(88,967)
Net income
245,021
-459.44%
(68,167)
-20.30%
(85,531)
-15.66%
Dividends
Dividend yield
Proceeds from repurchase of equity
27
50,914
(56,052)
BB yield
0.00%
-0.98%
1.99%
Debt
Debt current
4,262
5,101
5,270
Long-term debt
30,706
29,801
37,574
Deferred revenue
Other long-term liabilities
357
344
363
Net debt
(132,383)
(166,380)
(163,620)
Cash flow
Cash from operating activities
(18,257)
(46,985)
(83,421)
CAPEX
(820)
(3,279)
(3,416)
Cash from investing activities
(6,060)
(3,279)
(3,416)
Cash from financing activities
(6,703)
42,782
(61,561)
FCF
188,215
(75,003)
(114,496)
Balance
Cash
167,351
201,281
206,464
Long term investments
1,000
Excess cash
137,797
184,841
195,820
Stockholders' equity
(1,018,685)
(1,294,908)
(1,297,966)
Invested Capital
1,581,703
1,580,534
1,583,552
ROIC
15.90%
ROCE
3.94%
EV
Common stock shares outstanding
65,592
64,447
63,999
Price
188.20
133.93%
80.45
82.84%
44.00
-43.30%
Market cap
12,344,414
138.09%
5,184,761
84.12%
2,815,956
-38.58%
EV
12,212,031
5,018,381
2,652,336
EBITDA
32,265
(57,751)
(76,997)
EV/EBITDA
378.49
Interest
3,117
970
1,168
Interest/NOPBT
14.04%